Back to search

University of British Columbia

The role of gut bacterial translocation in the development of glucose intolerance and insulin resistance

Abstract

dc:description

Crohn disease (CD) is a form of inflammatory bowel disease (IBD) characterized by chronic, relapsing and remitting, or progressive inflammation of the gastrointestinal tract. Mounting evidence suggests that individuals with CD have an elevated risk of developing metabolic disease, such as type 2 diabetes (T2D), though the mechanisms linking these conditions remain poorly understood. CD and T2D share several pathophysiological features, including microbial dysbiosis, intestinal barrier dysfunction, and adipose tissue (AT) dysfunction. The Sly laboratory has previously characterized the Src homology 2 domain-containing inositolphosphate 5'-phosphatase (SHIP-/-) mouse model of CD-like ileitis, providing a model to investigate these shared mechanisms. Based on this, I hypothesized that chronic ileal inflammation in SHIP-/- mice would disrupt intestinal barrier function, facilitating bacterial translocation to mesenteric AT (MAT), contributing to the development of metabolic dysfunction (or disease). I confirmed that SHIP-/- mice exhibit additional features relevant to human CD, including intestinal barrier dysfunction, systemic AT inflammation, and fibrosis in MAT. SHIP-/- mice also had elevated pancreatic IL-1β concentrations. Despite displaying characteristics associated with both CD and T2D, SHIP-/- mice did not develop glucose intolerance and maintained insulin sensitivity comparable to SHIP+/+ controls. Furthermore, a Western diet challenge revealed that SHIP-/- mice may be resistant to diet-induced metabolic stress. Finally, supplementation with the prebiotic fibre inulin modestly improved intestinal barrier function and CD-like ileitis in SHIP-/- mice, with more pronounced effects observed in female mice. However, extra-intestinal inflammation was not consistently reduced, and in some cases, was exacerbated. Overall, these findings indicate that chronic intestinal inflammation and AT inflammation do not necessarily lead to metabolic dysfunction, highlighting a complex and context-dependent relationship between intestinal and extra-intestinal inflammation and metabolic health in CD.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Microbiology and Immunology
Grantor dc:publisher
University of British Columbia
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Bender-Thorsen, Chloé
Contributors dc:contributor
  • Sly, Laura

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/93593

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Bender-Thorsen, Chloé. The role of gut bacterial translocation in the development of glucose intolerance and insulin resistance. master's thesis, University of British Columbia, 2026. http://hdl.handle.net/2429/93593